Confirming cross-protection of bivalent HPV vaccine
- PMID: 28965956
- DOI: 10.1016/S1473-3099(17)30539-X
Confirming cross-protection of bivalent HPV vaccine
Comment on
-
Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study.Lancet Infect Dis. 2017 Dec;17(12):1293-1302. doi: 10.1016/S1473-3099(17)30468-1. Epub 2017 Sep 28. Lancet Infect Dis. 2017. PMID: 28965955
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources